Stanford University
Showing 6,401-6,500 of 13,044 Results
-
Daniel Yuhang Li
Instructor, Medicine - Cardiovascular Medicine
BioI am a physician scientist in the Division of Cardiology at Stanford. My clinical interest is at the intersection of inflammation, autoimmunity and cardiovascular disease in a field called 'Cardio-Rheumatology'. Patients with rheumatologic diseases typically have an elevated cardiovascular disease risk profile along with an insidious onset. Moreover, with the ever-expanding biologic drug formulary for patients, it is important for us to characterize the cardiovascular effects of these medications. In my research, I believe that understanding how inflammatory and autoimmune mechanisms modify coronary artery disease can help us develop a novel perspective towards treating atherosclerosis beyond lipid lowering. My research goal is to advance novel therapeutics for atherosclerosis by leveraging my expertise in genetics, computational biology, and experience with diverse model organism perturbation models. My strategy employs a ‘systems’ approach, starting with human population variations at the genetic level and integrating findings across RNA, protein, and model organism studies. This comprehensive synthesis aims to grasp the overarching biological narrative, thereby facilitating the development of translational therapies that transform concepts from bench to bedside.
-
Dayan J. Li, MD, PhD
Clinical Scholar, Dermatology
Postdoctoral Scholar, Pediatric SurgeryCurrent Research and Scholarly InterestsWound healing, cutaneous fibrosis
-
Gordon Li, MD
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly Interests1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery. -
Y. Howard Li
Postdoctoral Scholar, Ophthalmology
BioDr. Yuanhao Howard Li received his B.S. and Ph.D. in Brain and Cognitive Sciences at the University of Rochester, and he is currently a Postdoctoral Scholar in the Department of Ophthalmology at Stanford School of Medicine. His research is focused on how eye movements shape visual perception and how, in return, the oculomotor system utilizes eye movements to optimize visual information processing. His current projects apply eye-tracking and computational models to investigate and relationship between anatomical structure and oculomotor behavior in clinical populations with visual field impairment or abnormal motor control. This research aims to provide a better understanding of our brains and eyes, as well as potential applications in disease diagnosis and rehabilitation.
-
Jiawei Li
Postdoctoral Scholar, Cardiovascular Institute
BioMy research interests include organoids, engineering, and AI.
-
Jin Billy Li
Professor of Genetics
Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.
-
Lei Li
Postdoctoral Scholar, Psychiatry
BioPh.D., University of Electronic Science and Technology of China, Biomedical engineering 2024
B.E., University of Electronic Science and Technology of China, Biomedical engineering2019 -
Lingyin Li
Professor of Biochemistry
BioDr. Li is a professor in the Biochemistry Department and ChEM-H Institute at Stanford. She is also a core investigator of the Arc Institute. Her lab works on understanding biochemical mechanisms of the immunotransmitter cGAMP and harnessing it to treat cancer and autoimmunity. She majored in chemistry at University of Science and Technology of China and graduated with a B. En in 2003. She then trained with Dr. Laura Kiessling, a pioneer in chemical biology, at University of Wisconsin-Madison and graduated with a Ph.D in chemistry in 2010. She obtained her postdoctoral training with Dr. Timothy Mitchison at Harvard Medical School, who introduced her to the field of chemical immunology. She started her lab at Stanford in 2015.
-
Nina Li
Community Program Manager, Stanford CARE, Medicine - Med/Family and Community Medicine
Current Role at StanfordCommunity Program Manager, Stanford CARE
-
Ron Li
Clinical Associate Professor, Medicine
BioRon Li is a Clinical Associate Professor of Medicine in the Division of Hospital Medicine and Center for Biomedical Informatics Research at Stanford University School of Medicine. As the Medical Informatics Director for Digital Health at Stanford Health Care, he provides medical and informatics direction for the health system's enterprise digital health portfolio, including expanding digital referral networks and virtual care modalities. He is also the founding Medical Director for Stanford Health Care at Home and the co-founder and Director for the Stanford Emerging Applications Lab (SEAL), which helps clinicians and staff build ideas into novel digital products that are prototyped and tested for care delivery at Stanford Health Care.
Ron's academic interests focus on the "delivery science" of new technological capabilities such as digital and artificial intelligence in healthcare and how to design, implement, and evaluate new tech enabled models of care delivery. Ron's work spans across multiple disciplines, including clinical medicine, data science, digital health, information technology, design thinking, process improvement, and implementation science. He has consulted for various companies in the digital health and artificial intelligence space. He is an attending physician on the inpatient medicine teaching service at Stanford Hospital and is the Associate Program Director for the Stanford Clinical Informatics Fellowship. -
Ruijiang Li
Associate Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsMy lab's research is focused on the development of imaging and molecular biomarkers to improve cancer detection, diagnosis, prognostication, and prediction of therapy response. Our ultimate goal is to translate these biomarkers into clinical practice to guide optimal management and therapeutic decisions for precision cancer medicine.
-
Sally S. Li
Executive Director, Medicine - Med/Family and Community Medicine
Current Role at StanfordExecutive Director, Center for Asian Health Research and Education (CARE)
-
Yijie (Jamie) Li
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioI am a postdoctoral scholar at Stanford University, working on longitudinal wearable data to study interventions for diabetes and childhood obesity. I use computational and machine learning methods to extract actionable insights from high-resolution health data to improve treatment outcomes. Previously, I completed my Ph.D. in Computer Science at the University of Tulsa, focusing on machine learning for major depressive disorder using genomics, gene age, and neurofeedback. I also hold master’s degrees in Applied Economics and Finance from UC Santa Cruz and in Accountancy from the University of Tulsa, where I worked on financial modeling and stock market analysis.
-
Zhongxiao Li
Postdoctoral Scholar, Radiation Physics
BioZhongxiao Li is a postdoctoral researcher in Professor Ruijiang Li's lab at Stanford Medicine. His research focuses on computational biology and bioinformatics, particularly the development of deep learning methods for computational pathology and spatial transcriptomics/proteomics. Previously, his work has included developing machine learning models for histopathological image analysis, understanding gene regulation, and analyzing biological sequences.
-
Zongbo Li
Postdoctoral Scholar, Health Policy
BioZongbo Li, PhD, is a postdoctoral researcher at Stanford Health Policy. His research focuses on applying simulation modeling and cost-effectiveness analysis to inform policy decisions related to substance use and infectious diseases. He evaluates overdose prevention interventions, including naloxone distribution and medications for opioid use disorder, with particular attention to vulnerable populations such as people who are incarcerated. His work also encompasses modeling infectious diseases and evaluating interventions for COVID-19, HIV, and HCV. Zongbo earned his PhD in Health Services Research, Policy & Administration from the University of Minnesota.
-
April Shichu Liang
Clinical Assistant Professor, Medicine
BioApril S. Liang, M.D., is a Board-Certified internist and Clinical Informaticist. She serves as Clinical Assistant Professor in the Stanford Division of Hospital Medicine as well as Medical Informatics Director. Dr. Liang holds a B.S.E. in Computer Science from Princeton University and an M.D. from UCSF School of Medicine. She completed Internal Medicine residency at UCSF and Clinical Informatics fellowship at Stanford. Dr. Liang’s informatics interests include the implementation of AI tools in healthcare and data-driven quality improvement. Her past work includes the integrating a machine learning-driven clinical decision support tool in the EHR targeting lab overutilization and measuring the impact of ambient AI scribes on clinician documentation time.
-
Jiahao Liang
Ph.D. Student in Molecular and Cellular Physiology, admitted Autumn 2020
OTL Intern, Office of Technology Licensing (OTL)BioI'm currently a 6th-year Ph.D. student in Molecular & Cellular Physiology and an intern at the Office of Technology Licensing. I study how the spatial organization and structural conformation of synaptic proteins regulate synaptic transmission.
-
Richard Liang
MD Student with Scholarly Concentration in Health Services & Policy Research / Global Health, expected graduation Spring 2026
Ph.D. Student in Epidemiology and Clinical Research with Scholarly Concentration in Health Services & Policy Research / Global Health, admitted Autumn 2022
MSTP Student
Master of Arts Student in East Asian Studies, admitted Spring 2024Current Research and Scholarly InterestsPrimary research interests include:
- applications of advanced epidemiological methods
- life course health and social epidemiology
- bridging population health and basic science research
Clinical & health services research topics have included:
- maternal/child health
- geriatrics/aging
- dermatology, particularly inflammatory skin diseases
Google Scholar Profile: https://scholar.google.com/citations?user=WtCbIZAAAAAJ -
Charles Liao
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsEducational Curriculum: Working with Professional Interpreters
-
Joseph Liao, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Joseph Liao, M.D., is a double board-certified pain management specialist and anesthesiologist at the Stanford University School of Medicine, where he brings a wealth of expertise to the Department of Anesthesiology, Perioperative and Pain Medicine.
His clinical interests span a wide range of pain conditions with an emphasis on back pain, neck pain, joint pain, nerve pain, cancer-related pain, chronic post-surgical pain, and chronic post-traumatic pain. He specializes in neuromodulation, such as spinal cord stimulation, peripheral nerve stimulation, restorative neuromodulation, and dorsal root ganglion stimulation. Dr. Liao’s expertise extends to minimally invasive surgical spine interventions, using techniques like radiofrequency ablation, basivertebral nerve ablation, percutaneous decompression, sacroiliac joint fusion, and steroid injections. He is skilled in using ultrasonography and fluoroscopy to address spine, degenerative joint, and musculoskeletal diseases, as well as neurolysis and ablation for cancer-related pain.
In his research, Dr. Liao focuses on innovative therapies through neuromodulation and minimally invasive spine interventions, with his work published in prestigious peer-reviewed journals such as Anesthesiology and Pain Medicine. He serves as an ad hoc reviewer for multiple pain and anesthesiology journals. He is actively engaged in presenting and teaching at national and international conferences.
Dr. Liao is an avid patient and physician advocate. He takes pride in facilitating safe care and enjoys teaching other physicians how to safely deliver anesthetics and pain care and limit injuries in various forums. He adheres to the philosophy of applying the right treatment for the right patient at the right time. His goal is to utilize minimally invasive interventions to enhance functionality, elevate quality of life, and alleviate pain.
He serves on leadership boards and is affiliated with numerous esteemed medical associations such as the American Society of Interventional Pain Physicians, American Society of Pain and Neuroscience, North American Neuromodulation Society, International Association for the Study of Pain, American Academy of Pain Medicine, Pacific Spine and Pain Society, California Society of Interventional Pain Physicians, American Society of Anesthesiologists, American Association for the Surgery of Trauma, Society of Critical Care Medicine, and World Academy of Pain Medicine United. -
Joseph C. Liao
Kathryn Simmons Stamey Professor
Current Research and Scholarly InterestsThe overarching theme of my scholarship is to develop precision diagnostics in imaging and biomarkers to guide the delivery of precision therapy for urological diseases including bladder cancer, urinary tract infections, and kidney stone disease.
-
Ronglih Liao
Douglass M. and Nola Leishman Professor of Cardiovascular Disease
BioDr. Liao is a Professor of Medicine and co-Director of Stanford Cardiac Amyloid Center. The major goal of her research program focuses on understanding the mechanisms that underlie the pathophysiology of heart failure and developing novel treatments to combat this process. Her laboratory has played an international leading role in the study of amyloid light chain (AL) cardiomyopathy, a rare and fatal form of cardiovascular disease. We have described the underlying pathophysiologic basis for amyloid cardiomyopathy and found that the circulating amyloidogenic light chain proteins that characterize this disease directly result in a specific cardiotoxic response. Consequently, our research work has redefined AL cardiomyopathy and has raised new treatment approaches. More recently, her research efforts have expanded to include transthyretin (ATTR) cardiac amyloidosis.
In line with her goal of revealing novel therapeutic strategies for patients with cardiovascular disease, our efforts have also focused on characterizing and harnessing endogenous cardiac regenerative mechanisms. Her laboratory initially demonstrated the therapeutic potential of exogenous primitive muscle cells delivered to the injured heart. This work was among the earliest milestones in the field and served as the basis for an international trial of cell-based therapy. Subsequently, Liao lab identified and characterized a population of cardiac progenitor cells and its relationship and dynamic activity following cardiac injury in the adult heart. Her laboratory aims to reveal the molecular mechanisms regulating the endogenous regenerative capacity of the heart and to harness such repair mechanisms for the treatment of cardiovascular disease. Dr. Liao has lectured extensively on both amyloid cardiomyopathy and stem cell biology, and have maintained a history of independent NIH funding in these areas for more than two decades.
Over the course of her academic career, she has taken the greatest pride in mentoring the next generation of scientists. Dr. Liao has had the privilege to supervise several dozen students, postdoctoral fellows, and junior faculty, many of whom have gone on to independent academic careers at the highest institutions. Her contribution to the advancement of scientific knowledge also includes lecturing at various university and academic institutions as well as at scores of conferences and symposia locally, nationally, and internationally. -
Y. Joyce Liao, MD, PhD
Stanford Medicine Professor of Ophthalmology and Professor of Neurology and Neurological Sciences
Current Research and Scholarly InterestsIschemic optic neuropathy
Stem cell transplantation
Optic neuropathy
Optic neuritis
Eye movement disorders
Reading
Parkinson's disease
Multiple sclerosis -
Yungting Liao
Clinical Associate Professor, Pediatrics
Current Research and Scholarly Interestsclinical informatics, quality improvement
-
Cara A. Liebert, MD, FACS
Clinical Assistant Professor, Surgery - General Surgery
Current Research and Scholarly InterestsCurrent research interests include Surgical Education and Minimally Invasive Surgery. Primary research focus is the development, implementation, and collection of validity evidence for ENTRUST, an online virtual patient simulation platform for assessment of clinical decision-making.
-
Michaela Liedtke
CKD Family Professor
Current Research and Scholarly Interests1) Design of phase I/II trials for the treatment of Multiple Myeloma and Amyloidosis
2) Conduct of clinical trials to improve the treatment of patients with acute lymphoblastic leukemia (ALL)
3) Outcomes research using clinical databases for patients with Multiple Myeloma and Amyloidosis -
Geoffrey Lighthall
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsResearch Interests
I1. Care of the critically ill outside of the ICU
A. Development and evaluation of Medical Emergency Teams (aka. Rapid
Response Teams)
B. Detecting deterioration of non-ICU patients
C. Cardiac arrest teams
II. Training for patient care crises -- emphasis on use of patient simulation methods
A. ICU team training
B. Simulation in medical student ICU education
C. Resuscitation skills for code blue and RRT responses -
Theresa Lii, M.D., M.S.
Instructor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsEvaluating ketamine for chronic pain: dosing, predictors, and opioid outcomes
-
Joanna E. Liliental, PhD
Director, TRAM, M-TRAM, TASC, Med/TRAM
Current Role at StanfordExecutive Director, Master's in TRAM (M-TRAM)
https://med.stanford.edu/tram/masters-program.html
Director, Translational Applications Service Center (TASC)
http://tasc.stanford.edu
Associate Director, Translational Research and Applied Medicine (TRAM) Program
http://tram.stanford.edu
Senior Research Scientist, Stanford School of Medicine
Instructor of University Courses: MED221,MED121, MED212A
Member, Stanford Cancer Institute -
Celine Jia Rong Lim
Postdoctoral Scholar, Psychiatry
BioDr. Celine Lim is a Child Psychology Postdoctoral Fellow focusing on adolescent Dialectical Behavior Therapy (DBT) at Stanford School of Medicine, Department of Psychiatry and Behavioral Sciences. She earned her Doctor of Psychology (Psy.D.) in Clinical Psychology from the University of Indianapolis. Dr. Lim completed her pre-doctoral internship at the SUNY Upstate Medical University on the child and adolescent track. Her clinical experience includes a wide range settings: university counseling center, community mental health, academic medical center, private practice, inpatient psychiatric units, consultation-liaison services, and primary integrated care. She has a strong interest in providing evidence-based therapy to adolescents and families struggling with severe emotional dysregulation and complex trauma histories.
-
Donghyun Lim
Affiliate, Medicine - Med/Family and Community Medicine
BioDonghyun Lim is a research fellow at the Stanford Center for Asian Health Research and Education (CARE), part of the Stanford University School of Medicine. His work focuses on interdisciplinary research that addresses health disparities affecting Asian and Asian American populations. With a background in neuroscience and a strong interest in translational science, he aims to bridge biomedical research and public health to develop culturally responsive and equitable healthcare solutions.
